Oct4 mRNA, Human
Add To Cart |
Order Offline
T: 877.228.9783
F: 617.812.5900 E: orders@stemgent.com |


Product Overview
Stemgent Oct4 mRNA encodes the Oct4 protein commonly used in cellular reprogramming systems for the generation of induced pluripotent stem (iPS) cells. This in vitro transcribed mRNA incorporates both pseudouridine and 5-methylcytidine modified nucleotides to minimize the cellular interferon response to single stranded RNA.1,2 Repeated transfection of Oct4 mRNA in combination with mRNAs encoding Klf4, Sox2, Lin-28 and c-Myc has been shown to reprogram human fibroblasts.2
Product Specifications
Size
20 μg
Formulation
100 ng/μl in RNase-free TE buffer, pH 7.0
Storage and Stability
Store at or below -70°C. Stable for a minimum of 3 months from date of receipt when stored as directed. Wear gloves when handling this product. Use RNase-free tubes and barrier pipette tips. Thaw on ice. Keep on ice until the sample is removed. Avoid multiple freezing and thawing cycles (<5). Aliquot to experimental quantities.
Quality Control
Proper protein expression and localization have been confirmed by immunocytochemistry.
Recommended Usage
Stemgent Oct4 mRNA, Human should be transfected using a protocol specifically optimized for the cell type used in the experiment.
Related Products
- Stemgent Klf4 mRNA, Human (Cat.No.05-0015)
- Stemgent Sox2 mRNA, Human (Cat.No.05-0016)
- Stemgent c-Myc mRNA, Human (Cat.No.05-0018)
- Stemgent Lin-28 mRNA, Human (Cat.No.05-0017)
- Stemgent nGFP mRNA (Cat.No.05-0019)
- Stemgent mRNA Reprogramming Factors Set: hOKSML (Cat.No.00-0067)
- Stemfect™ RNA Transfection Kit (Cat.No.00-0069)
- Stemfactor™ Fibroblast Growth Factor-basic (Human Recombinant) (Cat.No.03-0002)
- Stemolecule™ Y27632 (Cat.No.04-0012)
Notice to Purchaser
This product is intended for research purposes only. It may not be used for (i) any human or veterinary use, including without limitation therapeutic and prophylactic use, (ii) any clinical use, including without limitation diagnostic and prognostic use, (iii) any use in delivery to and/or modification of cells that are intended for clinical, diagnostic or medicinal use, including without limitation, cell-based therapy, (iv)any commercial purposes, including without limitation the performance of contract research or provision of services to a third party and the manufacture of products for general sale. Any use of this product for any of the abovementioned purposes requires a license from the Massachusetts Institute of Technology.
Specification Sheets
Safety Data Sheets
Manuals
Product Sheets
References
- Angel, M., and Yanik, M.F. (2010) Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 5: e11756.
- Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A., Daley, D.Q., Brack, A.S., Collins, J.J., Cowan, C., Schlaeger, T.M., and Rossi, D.J. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630.
- Yakubov, E., Rechavi, G., Rozenblatt, S., and Givol, D. (2010) Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun. 394: 189-193.
Stemgent Comments and Reviews (0)
No comments or reviews yet. Be the first to leave a review.
Add a Comment
You must log-in or register as a Stemgent member to submit a comment.
You are fully responsible for the content you post. We encourage collaboration and helpful reviews among scientists and will use this feature to conduct helpful reviews of our products. Content that includes profanity, personal attacks or antisocial behavior (such as "spamming" or "trolling"), or other inappropriate content or material will be removed. We reserve the right to block any user who violates our terms of use, including removing all content posted by that user.